10-Q
Quarterly Report
AMERICAN HEALTHCARE REIT, INC.
AHR
NYSE
CIK: 1632970
File #: 001-41951
Balance Sheet
58 line items · 2 periods
XBRL
| Item | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|
ASSETS | ||
Real estate investments, net | 3,478,773,000 | 3,425,438,000 |
United States | 3,436,208,000 | 3,382,115,000 |
International | 42,565,000 | 43,323,000 |
Debt security investment, net | 87,984,000 | 86,935,000 |
Cash and cash equivalents | 77,026,000 | 43,445,000 |
Restricted cash | 47,505,000 | 47,337,000 |
Accounts and other receivables, net | 215,881,000 | 185,379,000 |
Identified intangible assets, net | 187,814,000 | 180,470,000 |
Goodwill | 234,942,000 | 234,942,000 |
2024 Acquisitions | 0 | — |
Integrated senior health campuses | 168,177,000 | 168,177,000 |
OM | 47,812,000 | 47,812,000 |
Triple-net leased properties | 18,953,000 | 18,953,000 |
Operating lease right-of-use assets, net | 221,575,000 | 227,846,000 |
Other assets, net | 151,930,000 | 146,141,000 |
Total assets | 4,703,430,000 | 4,577,933,000 |
Integrated senior health campuses | 2,241,792,000 | 2,197,762,000 |
OM | 1,213,664,000 | 1,232,310,000 |
SHOP | 716,923,000 | 630,373,000 |
Triple-net leased properties | 499,824,000 | 502,836,000 |
Other | 31,227,000 | 14,652,000 |
LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND EQUITY | ||
Liabilities: | ||
Mortgage loans payable, net | 1,228,435,000 | 1,302,396,000 |
Lines of credit and term loan, net | 759,308,000 | 1,223,967,000 |
Line of Credit - 2024 Credit Agreement | 550,000,000 | — |
Revolving Credit Facility - 2019 Trilogy Credit Facility | 210,000,000 | 309,823,000 |
Line of Credit - 2022 Credit Agreement | — | 914,900,000 |
Accounts payable and accrued liabilities | 257,283,000 | 242,905,000 |
Identified intangible liabilities, net | 5,805,000 | 6,095,000 |
Below-Market Lease | 5,805,000 | 6,095,000 |
Financing obligations | 41,101,000 | 41,756,000 |
Operating lease liabilities | 219,767,000 | 225,502,000 |
Security deposits, prepaid rent and other liabilities | 48,933,000 | 76,134,000 |
Total liabilities | 2,560,632,000 | 3,118,755,000 |
Redeemable noncontrolling interests | 11,636,000 | 33,843,000 |
Equity: | ||
Stockholders’ equity: | ||
Preferred stock, $0.01 par value per share; 200,000,000 shares authorized; none issued and outstanding | 0 | 0 |
Common Stock | 644,000 | 0 |
Common Class T | 194,000 | 194,000 |
Common Class I | 467,000 | 467,000 |
Additional paid-in capital | 3,275,252,000 | 2,548,307,000 |
Accumulated deficit | (1,313,190,000) | (1,276,222,000) |
Accumulated other comprehensive loss | (2,468,000) | (2,425,000) |
Total stockholders’ equity | 1,960,899,000 | 1,270,321,000 |
Noncontrolling interests | 170,263,000 | 155,014,000 |
Total equity | 2,131,162,000 | 1,425,335,000 |
Common Stock - Common Stock | 644,000 | 0 |
Common Class T - Common Stock | 194,000 | 194,000 |
Common Class I - Common Stock | 467,000 | 467,000 |
Additional Paid-In Capital | 3,275,252,000 | 2,548,307,000 |
Accumulated Deficit | (1,313,190,000) | (1,276,222,000) |
Accumulated Other Comprehensive Loss | (2,468,000) | (2,425,000) |
Total Stockholders' Equity | 1,960,899,000 | 1,270,321,000 |
Noncontrolling Interests | 170,263,000 | 155,014,000 |
Total liabilities, redeemable noncontrolling interests and equity | 4,703,430,000 | 4,577,933,000 |